UBR1
UBR1 (ubiquitin protein ligase E3 component n-recognin 1) is the recognition component of the N-end rule pathway, an E3 ubiquitin-protein ligase that binds proteins with destabilising N-terminal residues and targets them for degradation. It also acts as a negative regulator of leucine-mTOR signalling. Browse Assay Genie's current range of UBR1 research reagents below, or read on for the biology behind the target.
UBR1 is an E3 ubiquitin-protein ligase and a component of the N-end rule pathway, one of the proteolytic pathways of the ubiquitin system. It recognises and binds proteins bearing specific N-terminal residues that are destabilising according to the N-end rule. Binding leads to formation of a substrate-linked multiubiquitin chain and, ultimately, degradation of the substrate. UBR1 recognises both type-1 N-degrons, which contain positively charged residues (Arg, Lys and His), and type-2 N-degrons, which contain bulky hydrophobic residues.
The enzyme does not ubiquitinate proteins that are acetylated at the N-terminus, whereas it binds methylated N-degrons strongly. UBR1 also binds leucine and acts as a negative regulator of the leucine-mTOR signalling pathway, thereby controlling cell growth. The UBR1 protein localises to the cytosol and carries both a RING-type zinc finger and a UBR-type zinc finger. It belongs to the E3 ubiquitin-protein ligase UBR1-like family.
The UBR1 gene is classed by HGNC among the ubiquitin protein ligase E3 component n-recognins and among the RING finger E3 ubiquitin protein ligases. Mutations in the UBR1 gene have been associated with Johanson-Blizzard syndrome. A mouse ortholog, Ubr1, is recorded, which makes the protein accessible to comparative studies of N-end rule degradation. Related n-recognins include UBR4 and UBR5.
UBR1 recognises type-1 and type-2 N-degrons and drives ubiquitination and degradation of substrates, making it central to studies of N-terminal degradation signals.
UBR1 binds leucine and negatively regulates leucine-mTOR signalling, linking N-end rule components to the control of cell growth.
As a RING-type E3 ligase that builds substrate-linked multiubiquitin chains, UBR1 is a model for substrate recognition in the ubiquitin system.
Mutations in UBR1 have been associated with Johanson-Blizzard syndrome, making the gene relevant to research into this disorder.
UBR1 is an E3 ubiquitin-protein ligase of the N-end rule pathway. It binds proteins with destabilising N-terminal residues, promotes their ubiquitination and leads to their degradation. It also binds leucine and negatively regulates leucine-mTOR signalling, thereby controlling cell growth.
UBR1 recognises type-1 N-degrons, containing positively charged Arg, Lys or His, and type-2 N-degrons, containing bulky hydrophobic residues. It does not ubiquitinate proteins acetylated at the N-terminus, but it strongly binds methylated N-degrons. Its structure includes RING-type and UBR-type zinc fingers.
Mutations in the UBR1 gene have been associated with Johanson-Blizzard syndrome. A mouse ortholog, Ubr1, is recorded, supporting work in mouse models. Check the datasheet of any product for its validated reactivity.
Other UBR-family n-recognins and E3 ubiquitin ligases involved in ubiquitin-dependent degradation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IWV7; product specifications from Assay Genie datasheets.